Characteristics of the study sample
| Variable . | Overall study sample (N = 5,145) . | Participants not included in analyses (N = 3,167) . | Participants included in analyses (N = 1,978) . | P value* . | Participants with baseline and year 1 accelerometry data only (N = 198) . | Participants with baseline and year 4 accelerometry data only (N = 352) . |
|---|---|---|---|---|---|---|
| Age at randomization (years) | 58.7 (6.8) | 58.5 (6.8) | 59.1 (6.8) | 0.0013 | 59.8 (6.7) | 57.7 (7.0) |
| Female, N (%) | 3,063 (59.5) | 1,930 (60.9) | 1,133 (57.3) | 0.0093 | 114 (57.6) | 211 (59.9) |
| Baseline history of CVD, N (%) | 714 (13.9) | 410 (12.9) | 304 (15.4) | 0.0145 | 41 (20.7) | 41 (11.6) |
| Diabetes duration at baseline (years) | 6.8 (6.5) | 6.7 (6.6) | 6.9 (6.5) | 0.3733 | 8.0 (6.6) | 6.7 (6.5) |
| Baseline insulin use, N (%) | 792 (16.0) | 493 (16.2) | 299 (15.6) | 0.5766 | 35 (18.0) | 50 (14.7) |
| Baseline BMI (kg/m2) | 35.9 (5.9) | 35.7 (5.8) | 36.4 (6.0) | <0.0001 | 36.7 (5.7) | 37.1 (6.1) |
| Baseline weight (kg) | 100.7 (19.3) | 99.4 (19.3) | 102.8 (19.0) | <0.0001 | 104.0 (19.1) | 104.2 (19.7) |
| Year 1 weight change from baseline (kg) | −4.8 (7.6) | −4.6 (7.5) | −5.1 (7.7) | 0.0355 | −4.6 (7.9) | −5.0 (7.3) |
| Year 4 weight change from baseline (kg) | −3.1 (8.8) | −3.0 (8.9) | −3.3 (8.8) | 0.2199 | −2.2 (7.6) | −3.6 (9.7) |
| Baseline cardiorespiratory fitness (maximal METS) | 7.2 (2.0) | 7.3 (2.0) | 7.1 (1.9) | 0.0037 | 6.9 (1.9) | 7.2 (1.9) |
| Variable . | Overall study sample (N = 5,145) . | Participants not included in analyses (N = 3,167) . | Participants included in analyses (N = 1,978) . | P value* . | Participants with baseline and year 1 accelerometry data only (N = 198) . | Participants with baseline and year 4 accelerometry data only (N = 352) . |
|---|---|---|---|---|---|---|
| Age at randomization (years) | 58.7 (6.8) | 58.5 (6.8) | 59.1 (6.8) | 0.0013 | 59.8 (6.7) | 57.7 (7.0) |
| Female, N (%) | 3,063 (59.5) | 1,930 (60.9) | 1,133 (57.3) | 0.0093 | 114 (57.6) | 211 (59.9) |
| Baseline history of CVD, N (%) | 714 (13.9) | 410 (12.9) | 304 (15.4) | 0.0145 | 41 (20.7) | 41 (11.6) |
| Diabetes duration at baseline (years) | 6.8 (6.5) | 6.7 (6.6) | 6.9 (6.5) | 0.3733 | 8.0 (6.6) | 6.7 (6.5) |
| Baseline insulin use, N (%) | 792 (16.0) | 493 (16.2) | 299 (15.6) | 0.5766 | 35 (18.0) | 50 (14.7) |
| Baseline BMI (kg/m2) | 35.9 (5.9) | 35.7 (5.8) | 36.4 (6.0) | <0.0001 | 36.7 (5.7) | 37.1 (6.1) |
| Baseline weight (kg) | 100.7 (19.3) | 99.4 (19.3) | 102.8 (19.0) | <0.0001 | 104.0 (19.1) | 104.2 (19.7) |
| Year 1 weight change from baseline (kg) | −4.8 (7.6) | −4.6 (7.5) | −5.1 (7.7) | 0.0355 | −4.6 (7.9) | −5.0 (7.3) |
| Year 4 weight change from baseline (kg) | −3.1 (8.8) | −3.0 (8.9) | −3.3 (8.8) | 0.2199 | −2.2 (7.6) | −3.6 (9.7) |
| Baseline cardiorespiratory fitness (maximal METS) | 7.2 (2.0) | 7.3 (2.0) | 7.1 (1.9) | 0.0037 | 6.9 (1.9) | 7.2 (1.9) |
Data are mean (SD) unless otherwise indicated.
P value represents the comparison of participants included and not included in the analyses.